We set sights on increasing the chemosensitivity of colon cancer cells to Epi through suppression of MDR transporters and apoptosis induction via inhibition of HuR-mediated galectin-3/β-catenin pathway. The gene discussed is ELAVL1; the disease is malignant colon neoplasm.